Investor Relations

Press Releases

Date Title and Summary View
Toggle Summary NanoString to Release Fourth Quarter and Fiscal Year 2019 Financial Results and Host Conference Call on Wednesday, February 26, 2020
SEATTLE --(BUSINESS WIRE)--Feb. 10, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced that the Company will release fourth quarter and fiscal year 2019 financial results after the close of the market on
View HTML
Toggle Summary Two Landmark Nature Publications use NanoString’s GeoMx Digital Spatial Profiling to Dissect Mechanisms of Response to Immunotherapy
Deep Molecular Profiling of Immune Cells Critical for Survival and Response to Therapy in Patients with Metastatic Melanoma SEATTLE --(BUSINESS WIRE)--Jan. 15, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced
View HTML
Toggle Summary NanoString Provides Preliminary Operational and Financial Results for Fourth Quarter and FY 2019
— FY19 Product and Service Revenue of $103.7 million , including GeoMx DSP Revenue of $10.8 million , Exceeds High End of Guidance Ranges — — Over 90 Cumulative GeoMx DSP Orders as of Year End — SEATTLE --(BUSINESS WIRE)--Jan. 12, 2020-- NanoString Technologies, Inc.
View HTML
Toggle Summary NanoString to Present at the 38th Annual JP Morgan Healthcare Conference
SEATTLE --(BUSINESS WIRE)--Jan. 2, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced that the company’s management is scheduled to present at the 38 th Annual JP Morgan Healthcare Conference in San Francisco .
View HTML
Toggle Summary NanoString Announces the Creation of the GeoMx Breast Cancer Consortium
Consortium Plans to Apply Spatial Analysis to Major Challenges in Breast Cancer Research SEATTLE --(BUSINESS WIRE)--Dec. 11, 2019-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced the formation of the GeoMx™ Breast
View HTML
Toggle Summary NanoString Announces Exclusive License of nCounter Diagnostic Assets and Rights to Veracyte
Creates Potential for Significantly Expanded Test Menu Sharpens NanoString’s Strategic Focus on Rapidly Growing Research Business Including Recent Launch of GeoMx Digital Spatial Profiler Strengthens Financial Profile through Capital Infusion and Streamlined Operations SEATTLE --(BUSINESS
View HTML
Toggle Summary Nature Medicine Publication Highlights Use of NanoString’s Hyb & Seq Technology to Perform Rapid Genotypic and Phenotypic Antibiotic Susceptibility Testing
Technology for Rapid Pathogen Identification and Phenotypic Antibiotic Susceptibility, Licensed from Broad Institute , Enables Testing Across a Wide Range of Pathogens SEATTLE --(BUSINESS WIRE)--Dec. 3, 2019-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for
View HTML
Toggle Summary NanoString to Present at the Evercore ISI 2nd Annual HealthCONx Conference
SEATTLE --(BUSINESS WIRE)--Nov. 25, 2019-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the Evercore ISI 2 nd Annual
View HTML
Toggle Summary NanoString to Present at the Stifel 2019 Healthcare Conference
SEATTLE --(BUSINESS WIRE)--Nov. 13, 2019-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the Stifel 2019 Healthcare
View HTML
Toggle Summary NanoString Highlights the Results of Research Presented at the 2019 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)
Presentations Include Data from More than Thirty NanoString-Related Abstracts Including Five Using the GeoMx Digital Spatial Profiler SEATTLE --(BUSINESS WIRE)--Nov. 7, 2019-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and
View HTML